Charles River Labs Files 8-K on Shareholder Vote Matters

TL;DR

CRL filed an 8-K for a shareholder vote. Nothing major to see here.

AI Summary

Charles River Laboratories International, Inc. filed an 8-K on May 10, 2024, reporting on matters submitted to a vote of security holders on May 8, 2024. The filing details the company's principal executive offices located at 251 Ballardvale Street, Wilmington, Massachusetts.

Why It Matters

This filing indicates that Charles River Laboratories held a shareholder vote, which is a routine but important corporate governance event that can impact company direction and shareholder relations.

Risk Assessment

Risk Level: low — The filing is a standard 8-K reporting a routine shareholder vote, with no immediate financial or operational risks indicated.

Key Players & Entities

• CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (company) — Registrant
• 251 Ballardvale Street, Wilmington, Massachusetts 01887 (location) — Principal Executive Offices
• May 8, 2024 (date) — Date of earliest event reported
• May 10, 2024 (date) — Date of Report

FAQ

Key Financial Figures

• $0.01 — ange on which registered Common stock, $0.01 par value CRL New York Stock Exchange

Filing Documents

• crl-20240508.htm (8-K) — 43KB
• 0001100682-24-000020.txt ( ) — 164KB
• crl-20240508.xsd (EX-101.SCH) — 2KB
• crl-20240508_lab.xml (EX-101.LAB) — 21KB
• crl-20240508_pre.xml (EX-101.PRE) — 12KB
• crl-20240508_htm.xml (XML) — 3KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders Charles River Laboratories International, Inc. (the "Company") held its Annual Meeting of Shareholders on May 8, 2024. For more information on the following proposals, see the Company's proxy statement dated March 29, 2024. At the Company's Annual Meeting, the following proposals were adopted by the votes specified below: (a) The following eleven (11) directors were elected to serve until our 2025 Annual Meeting of Shareholders and received the number of votes listed opposite each of their names below: Number of Shares Voted For Number of Shares Voted Against Number of Shares Abstained Broker Non-Votes James C. Foster 43,667,281 2,380,275 140,644 2,038,517 Nancy C. Andrews 45,474,179 688,931 25,090 2,038,517 Robert J. Bertolini 44,599,861 1,562,940 25,399 2,038,517 Reshema Kemps-Polanco 46,096,094 66,865 25,241 2,038,517 Deborah T. Kochevar 43,252,303 2,910,578 25,319 2,038,517 George Llado, Sr. 45,449,038 713,929 25,233 2,038,517 Martin W. Mackay 39,753,364 6,409,765 25,071 2,038,517 George E. Massaro 43,532,473 2,629,967 25,760 2,038,517 Craig B. Thompson 46,041,753 121,233 25,214 2,038,517 Richard F. Wallman 44,122,023 2,040,680 25,497 2,038,517 Virginia M. Wilson 45,342,311 820,481 25,408 2,038,517 (b) The shareholders approved, on an advisory, non-binding basis, the compensation of our named executive officers. For Against Abstain Broker Non-Votes 43,833,503 2,299,362 55,335 2,038,517 (c) The shareholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as our independent auditors for fiscal 2024. For Against Abstain Broker Non-Votes 45,612,837 2,586,704 27,176 0 (e) The shareholders did not approve the shareholder proposal submitted by PETA to publish a report on non-human primates imported by the Company. For Against Abstain Broker Non-Votes 11,428,432 34,538,572 221,196 2,038,517 Computershare Trust Company, N.A., our transfer agent, acte

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Date: May 10, 2024 By: /s/ Matthew L. Daniel Matthew L. Daniel, Corporate Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR